Loading clinical trials...
Loading clinical trials...
A Stage 1 Study of Community Reinforcement and Family Training for Treatment Drug Abuse Treatment Retention/HIV Risk Reduction
The planned research will adapt an intervention of known efficacy to target a new outcome of significant importance to public health. Specifically the Community Reinforcement and Family Training (CRAFT) procedures will be adapted, from reinforcing treatment entry, to reinforcing treatment retention and HIV risk behavior reduction in persons with opioid dependence who receive a Buprenorphine taper detoxification. The research plan includes three phases: 1) development of a manual guided therapy, 2) development of therapist training and fidelity measures and 3) a randomized pilot evaluation with 52 patients receiving either the new CRAFT treatment or treatment as usual.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Maryhaven
Columbus, Ohio, United States
Start Date
March 1, 2008
Primary Completion Date
June 1, 2012
Completion Date
June 1, 2013
Last Updated
August 14, 2012
104
ESTIMATED participants
CRAFT-T
BEHAVIORAL
Treatment as usual
BEHAVIORAL
Lead Sponsor
University of Cincinnati
Collaborators
NCT04430257
NCT05348317
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions